Related references
Note: Only part of the references are listed.Acute ethanol exposure-induced autophagy-mediated cardiac injury via activation of the ROS-JNK-Bcl-2 pathway
Zhongxin Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Genistein improves thyroid function in Hashimoto's thyroiditis patients through regulating Th1 cytokines
Kaili Zhang et al.
IMMUNOBIOLOGY (2017)
Genistein as antioxidant and antibrowning agents in in vivo and in vitro: A review
Md. Anisur Rahman Mazumder et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice
Yuan Yuan et al.
HYPERTENSION (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Compromised MAPK signaling in human diseases: an update
Eun Kyung Kim et al.
ARCHIVES OF TOXICOLOGY (2015)
Bioactivity of genistein: A review of in vitro and in vivo studies
Ajaz Ahmad Ganai et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice
Wei Qin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy
Michael Mutlak et al.
FRONTIERS IN PHARMACOLOGY (2015)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription
Haiyan Huang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Redox regulation of cardiac hypertrophy
Can M. Sag et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Ginsenoside Rb3 Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of JNK-Mediated NF-κB Pathway: A Mouse Cardiomyocyte Model
Lijia Ma et al.
PLOS ONE (2014)
Signaling effectors underlying pathologic growth and remodeling of the heart
Jop H. van Berlo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases
Ganji Purnachandra Nagaraju et al.
NUTRITION REVIEWS (2013)
Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function
Elizabeth R. Gilbert et al.
FOOD & FUNCTION (2013)
Genistein prevents isoproterenol-induced cardiac hypertrophy in rats
Subir Kumar Maulik et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Oxidative stress and cardiac hypertrophy: a review
Subir Kumar Maulik et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Esther E. Creemers et al.
CARDIOVASCULAR RESEARCH (2011)
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Toshinori Aoyagi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Genistein, an epigenome modifier during cancer prevention
Yukun Zhang et al.
EPIGENETICS (2011)
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling
Di-Fei Shen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart
Hideyuki Kinoshita et al.
CIRCULATION RESEARCH (2010)
Novel regulators and drug targets of cardiac hypertrophy
Piet Finckenberg et al.
JOURNAL OF HYPERTENSION (2010)
Molecular targets and regulators of cardiac hypertrophy
Rohini Agrawal et al.
PHARMACOLOGICAL RESEARCH (2010)
Molecular Mechanisms Underlying the Transition of Cardiac Hypertrophy to Heart Failure
Toru Oka et al.
CIRCULATION JOURNAL (2008)
Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity
Anna Elisa Valsecchi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Genistein modulate immune responses in collagen-induced rheumatoid arthritis model
Jingxuan Wang et al.
MATURITAS (2008)
Glycogen synthase kinase-3 beta - Actively inhibiting hypertrophy
Risto Kerkela et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
Kumar Pandya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Cardiac hypertrophy: A risk factor for QT-pProlongation and cardiac sudden death
YJ Kang
TOXICOLOGIC PATHOLOGY (2006)
Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: Cell biological implications
P Vangheluwe et al.
CELL CALCIUM (2005)
ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction
GX Zhang et al.
HYPERTENSION (2004)
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance
Z Abassi et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Genistein as an anti-inflammatory agent
M Verdrengh et al.
INFLAMMATION RESEARCH (2003)
Mitogen-activated protein kinases:: A new therapeutic target in cardiac pathology
T Ravingerová et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Gene expression in fibroblasts and fibrosis - Involvement in cardiac hypertrophy
I Manabe et al.
CIRCULATION RESEARCH (2002)
Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
OF Bueno et al.
CIRCULATION RESEARCH (2002)